Indication
β-Thalassemia Major
1 clinical trial
1 product
Product
CS-101Clinical trial
A Single-arm, Open-label Phase I Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamic Profile of a Single Dose of CS-101 Injection in Subjects With β-thalassemia MajorStatus: Recruiting, Estimated PCD: 2025-05-01